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Summary
We investigated how the type III secretion system
WxxxE effectors EspM2 of enterohaemorrhagic
Escherichia coli, which triggers stress fibre forma-
tion, and SifA of Salmonella enterica serovar Typh-
imurium, which is involved in intracellular survival,
modulate Rho GTPases. We identified a direct
interaction between EspM2 or SifA and nucleotide-
free RhoA. Nuclear Magnetic Resonance Spectros-
copy revealed that EspM2 has a similar fold to
SifA and the guanine nucleotide exchange factor
(GEF) effector SopE. EspM2 induced nucleotide
exchange in RhoA but not in Rac1 or H-Ras, while
SifA induced nucleotide exchange in none of them.
Mutating W70 of the WxxxE motif or L118 and I127
residues, which surround the catalytic loop,
affected the stability of EspM2. Substitution of
Q124, located within the catalytic loop of EspM2,
with alanine, greatly attenuated the RhoA GEF
activity in vitro and the ability of EspM2 to induce
stress fibres upon ectopic expression. These
results suggest that binding of SifA to RhoA does
not trigger nucleotide exchange while EspM2 is a
unique Rho GTPase GEF.
Introduction
Pathogenic bacteria use a variety of strategies to subvert
cellular and immunological functions to facilitate coloniza-
tion, multiplication and survival within the host. Several
Gram-negative pathogens, e.g. Salmonella enterica, Shi-
gella spp. and enteropathogenic and enterohaemorragic
Escherichia coli (EPEC and EHEC), encode a type III
secretion system (T3SS) which is central for their infection
strategy. T3SS are molecular syringes that allow trans-
location of effector proteins directly from the bacteria to
the cytoplasm of the host cell. Once translocated the
effectors subvert cellular processes to facilitate the par-
ticular infection style of the pathogen (Mota and Cornelis,
2005). To this end bacterial T3SS effectors often display
sequence, structural or functional similarities to eukaryotic
proteins.cmi_1423 654..664
Rho GTPases react to a range of intrinsic and extrinsic
stimuli in order to regulate a plethora of host cell signalling
networks most notably those involved in remodelling the
eukaryotic actin cytoskeleton and, as such, are prominent
targets of T3SS effectors (Finlay, 2005). RhoA, Cdc42
and Rac1, the most studied Rho GTPases, induce forma-
tion of stress fibres, filopodia and lamellipodia respec-
tively (Jaffe and Hall, 2005). To exert their control on these
cellular processes Rho GTPases act as molecular
switches cycling between GTP-bound ‘on’ and GDP-
bound ‘off’ conformations. Rho GTPases have well-
defined nucleotide and magnesium binding pocket,
constituted mainly by two polypeptides called Switch I and
II and by the phosphate-binding loop or P-loop. Mg2+ ions
are required for high-affinity binding of guanine nucle-
otides to Rho GTPases. The Switch I and II regions define
the major conformational differences between the GDP
and GTP bound forms; only the GTP-bound conformation
allows interactions of the Rho GTPases with their down-
stream effectors. The activation state of Rho GTPases is
modulated by three main categories of regulatory pro-
teins: (i) guanine nucleotide dissociation inhibitors (GDI)
that sequester GTPases in the cytosol in a GDP-bound
state, (ii) guanine nucleotide exchange factors (GEFs)
that catalyse the GDP/GTP exchange, and (iii) GTPase
activating proteins (GAPs) that inactivate the Rho
GTPases by stimulating their intrinsic GTPase activity.
Type III secretion system effectors use different mecha-
nisms to subvert Rho GTPases. For example, EPEC and
EHEC EspG and EspG2 indirectly activate RhoA by dis-
rupting microtubules, which leads to liberation of a RhoA-
specific GEF, GEF-H1 (Matsuzawa et al., 2004). Other
T3SS effectors modulate Rho GTPase directly as they
function as either GEFs or GAPs. For example, the Sal-
monella effector SopE directly activates Rac1 and Cdc42
leading to lamellipodia formation and promoting bacterial
invasion into non-phagocytic cells (Hardt et al., 1998). In
contrast, Salmonella uses the GAP T3SS effector SptP to
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stimulate the intrinsic Rho GTPase activity to restore cell
architecture following bacterial internalization (Fu and
Galan, 1999). SopE and SptP homologues have been
identified in different species including Burkholderia pseu-
domallei (BopE), Yersinia pseudotuberculosis (YopE)
and Pseudomonas aeruginosa (ExoS) (Goehring et al.,
1999; Von Pawel-Rammingen et al., 2000; Stevens et al.,
2003). By modulating the actin cytoskeleton via Rho
GTPases, YopE and ExoS inhibit bacterial uptake by
macrophages (Black and Bliska, 2000; Deng and Barbieri,
2008).
Based on a conserved motif comprising an invariant
tryptophan (W) and a glutamic acid (E) separated by three
variable amino acids, Alto et al. (2006) grouped together a
number of known T3SS effectors from Shigella (IpgB1
and IpgB2), Salmonella (SifA and SifB) and EPEC and
EHEC (Map) and termed them WxxxE effectors. Recently,
we identified new WxxxE effectors encoded by EPEC and
EHEC, EspM (Tobe et al., 2006) and EspT (Bulgin et al.,
2009). Ectopic expression of Map leads to filopodia for-
mation (Alto et al., 2006), IpgB2 and EspM trigger stress
fibres (Alto et al., 2006; Arbeloa et al., 2008) and IpgB1
and EspT induce membrane ruffles and lamellipodia (Alto
et al., 2006; Bulgin et al., 2009). These phenotypes are
typically associated with activated Cdc42, RhoA and Rac1
(Hall et al., 1993) respectively.
Alto et al. suggested that the WxxxE effectors, which
play important roles in cell invasion (IpgB proteins) and
intracellular survival (SifA), mimic the function of Rho
GTPases. Handa et al. (2007) subsequently demon-
strated that IpgB1 stimulates formation of membrane
ruffles by activating Rac1 through recruitment of the
Rac1-specific ELMO–Dock180 GEF complex. Moreover,
the structure of SifA in complex with the PH domain of
SKIP has shown that its C-terminus domain, which
includes the WxxxE motif, adopts a fold similar to SopE
(Ohlson et al., 2008). However, neither direct binding to
the Rho GTPases nor GEF activity was detected in this
study. Furthermore, we have recently reported that Map
(Berger et al., 2009), EspM (Arbeloa et al., 2008) and
EspT (Bulgin et al., 2009) activate the Rho GTPases
Cdc42, RhoA and Rac1. The aim of this study was to
determine the mechanism through which EspM2 activates
RhoA.
Results
EspM2 binds RhoA
We used His-EspM2 to investigate if activation of RhoA
involves a direct interaction. Although highly soluble, His-
EspM2 was unstable and appeared in two distinct bands
corresponding to the full-length effector and a spontane-
ous degradation product; N-terminal sequencing revealed
that the latter corresponds to EspM2 lacking the first 28
amino acids (EspM229–196) (Appendix S1 and Fig. S1).
Ectopic expression of EspM229–196 in Swiss 3T3 cells
resulted in stress fibre formation at the same level as
full-length EspM2 (Fig. S2), confirming that it retained
full biological activity. Consequently we have used
EspM229–196 throughout this study.
Surface plasmon resonance was used to probe the
interaction between His-EspM229–196 and His-RhoA. This
technique allows binding to be observed in real time by
the change in mass over the derivatized surface of a
sensor chip. RhoA was flowed (sequential injections
ranging from 0.05 mM to 50 mM) over an EspM229–196-
bound surface and displayed an increased rate of binding
with concentration confirming a specific interaction
(Fig. 1A). Free GDP or GTP added to the running buffer
inhibited formation of an EspM229–196–RhoA complex in a
nucleotide concentration-dependent manner (Fig. 1B).
GDP and GTP have the same effect as one another
(within experimental error), reducing the binding affinity of
EspM229–196 to RhoA by up to 67% in the nucleotide con-
centration range 0.5–8 mM.
As a control, Rac1 was flowed over the same
EspM229–196 surface and for any given GTPase concen-
tration showed substantially less binding (Fig. 1C), con-
firming the specificity of EspM229–196 for RhoA over other
GTPases. As recent data suggested that SifA might bind
RhoA (Ohlson et al., 2008), their direct interaction was
also tested. We found that His-SifA and His–RhoA
bound in a concentration-dependent manner (Fig. 1D),
and was inhibited by free GDP or GTP (data not shown).
Although high RhoA concentrations (mM range) were
required to see an interaction, EspM229–196–RhoA binding
was found to be long-lived. The interaction response
was followed for 1000 s after each injection, by which
time the rate of dissociation appeared to have fallen to
zero in an incompletely dissociated state. Dissociation
of the pre-formed EspM229–196–RhoA, as well as SifA–
RhoA, complexes could not be brought about by addi-
tion of 500 mM free GDP in running buffer (in the
presence or absence of 5 mM MgCl2, data not shown)
in contrast to the rapid dissociation of SopE–Cdc42
reported by Rudolph et al. (1999). Dissociation of
EspM229–196–RhoA proved to be more difficult than that
of SifA–RhoA, requiring high pH conditions (25 mM
NaOH, pH 12.4), where high ionic strength (1 M NaCl)
would suffice for the latter to bring the response back to
the pre-experiment level.
EspM2 stimulates guanine nucleotide exchange
in RhoA
We next investigated the ability of EspM229–196 to stimulate
guanine nucleotide exchange in RhoA and other
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GTPases in vitro using a RhoGEF exchange assay. This
spectroscopic assay measures fluorescent emission upon
insertion of N-methylanthraniloyl(mant)-GTP into the
nucleotide binding pocket of the GTPases (Rossman
et al., 2002). As shown in Fig. 2 inclusion of 250 mM
EDTA (positive control) in the assay induced efficient
nucleotide exchange in RhoA, Cdc42, Rac1 and H-Ras,
indicating that these proteins were biologically functional,
while a slow intrinsic nucleotide exchange activity was
detected in the presence of buffer alone (negative
control). The fluorescence intensity rose dramatically and
in a concentration-dependent manner when increasing
amounts of purified EspM229–196 were added to RhoA
(Fig. 2A). In contrast, EspM229–196 showed a weak
exchange activity in Cdc42 (Fig. 2B), whereas it had no
effect on Rac-1 and H-Ras (Fig. 2C and data not shown).
No change in fluorescence emission was detected when
EspM2 was incubated in the absence of any of the small
GTPases (Fig. 2D). Testing the GEF activity of SifA
revealed that it did not stimulate nucleotide exchange in
any of the tested Rho GTPases or H-Ras (Fig. 2E). These
results demonstrate that EspM229–196 is a specific RhoA
GEF, and that although SifA can bind RhoA it cannot
induce nucleotide exchange.
A B
C D
Fig. 1. RhoA binds directly to EspM2 and SifA.
A. Surface plasmon resonance showing concentration-dependent binding of RhoA to EspM229–196. Concentrations of RhoA varying from
0.05 mM to 50 mM were flowed at 50 ml min-1 (duration indicated by black bar) over a CM5 sensor chip with EspM229–196 covalently bound to
the surface. Control substituted signals are shown.
B. Inhibition of EspM229–196–RhoA interaction by GDP or GTP. For RhoA (4 mM) flowing over an EspM229–196-bound surface in buffer containing
GDP/GTP, the response maxima relative to response maxima in the absence of nucleotide are plotted with respect to GDP/GTP
concentration.
C. Binding of EspM229–196 to RhoA and Rac1. Averaged response maxima for three representative concentrations compare the strength of
EspM2 binding with the two GTPases.
D. Surface plasmon resonance demonstrates RhoA concentration dependence for binding SifA. Concentrations of SifA varying from
0.5 mM to 6 mM were flowed at 50 ml min-1 over a CM5 sensor chip with RhoA covalently bound to the surface.
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Fig. 2. EspM2 is a RhoA GEF.
A. EspM229–196 mediates loading of mant-GTP into RhoA. mant-GTP (0.5 mM) was incubated with 2 mM RhoA in presence of 250 mM EDTA
(squares), or 0.05–50 mM EspM229–196 (circles) or in presence of buffer only (triangles). The insertion of the mant-GTP into the nucleotide
binding pocket of RhoA in presence of EspM229–196 detected by an increase in the fluorescent emission was found to be concentration
dependent.
B. EspM229–196 weakly induces loading of mant-GTP into Cdc42. mant-GTP (0.5 mM) was incubated with 2 mM Cdc42 in presence of 250 mM
EDTA (squares), or 0.05–50 mM EspM229–196 (circles) or in presence of buffer only (triangles). Slow loading of mant-GTP into Cdc42 was only
detected when high concentrations of EspM229–196 were added.
C. EspM229–196 does not induce nucleotide exchange for Rac1. mant-GTP (0.5 mM) was incubated with 2 mM Rac1 in presence of 250 mM
EDTA (squares), or 0.05–50 mM EspM229–196 (circles) or in presence of buffer only (triangles). No efficient loading of man-GTP into Rac1 was
observed after incubation with up to 50 mM EspM229–196.
D. Incubation of 50 mM EspM229–196 in the exchange buffer alone did not change the fluorescence intensity.
E. SifA does not induce nucleotide exchange in RhoA, Cdc42, Rac1 or H-Ras. mant-GTP (0.5 mM) was incubated with 2 mM RhoA (blue
circles), Cdc42 (pink circles), Rac1 (green circles) or H-Ras (orange circles) in presence of 5 mM SifA. No loading of man-GTP into any of the
small GTPases tested was observed in these conditions. Results shown are the average of three independent experiments.
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Mapping the EspM2 interface of the
EspM2–RhoA complex
Although EspM229–196 is significantly more stable than full
length, it has a proposenity to aggregate that can only be
alleviated by high salt concentrations and pH values.
These factors make EspM2 particularly unsuitable for
structural study by either NMR or crystallography. Indeed,
despite exhaustive attempts EspM229–196 and full-length
EspM2 proved refractory to crystallization (see Appen-
dix S1). Although deuteration of EspM2 was not possible,
~70% of the backbone resonances could be confidently
assigned using standard triple resonance NMR method-
ology on a 15N 13C-labelled sample. NMR was then used
to monitor the interaction of RhoA with EspM229–196 at a
residue-specific level. At 1:1 molar ratio significant
changes in 1H 15N TROSY-HSQC spectra of EspM2 were
detectable; and it was possible to determine which
assigned EspM2 residues were within intimate proximity
of RhoA upon complex formation (Fig. 3A). After the addi-
tion of sevenfold molar excess RhoA, peaks correspond-
ing to structured regions of EspM229–196 had broadened to
such an extent that many were no longer visible and
furthermore, addition of 5 mM GTP to the sample did not
result in dissociation of the complex.
The chemical shift index based on NMR data for 13Ca,
13Cb and 13C′ resonances (Wishart et al., 1993) reveals
that EspM2 is primarily helical (albeit for an unstructured
~30 residue region at the N-terminus), which is consistent
with secondary structure prediction with PSIPRED
(Jones, 1999) (Fig. S1). The helical content and locations
are similar to that of the C-terminal domain of SifA whose
crystal structure has been recently determined (Fig. S3)
(pdb:3cxb; Ohlson et al., 2008). Based on these data we
created a sequence alignment between EspM229–196 and
SifA, and together with the crystal structure we computed
a homology model of EspM229–196 using SWISS-MODEL
(Arnold et al., 2006). NMR chemical shift data from RhoA
titration was then mapped onto the model of EspM229–196
(Fig. 3B). Furthermore, a model of the complex with RhoA
was created by superposing the EspM229–196 homology
model and the crystal structure of RhoA (pdb:1xcg; Dere-
wenda et al., 2004) onto the crystal structures of SopE
and Cdc42, respectively, within the SopE–Cdc42 complex
(pdb:1gzs; Buchwald et al., 2002) (Fig. 3C). In this model
of the EspM2–RhoA complex, almost all of the perturbed
Fig. 3. Model of EspM229–196 and the EspM229–196–RhoA complex.
A. 1H 15N TROSY-HSQC titration of RhoA against EspM229–196.
Black peaks show no addition of RhoA while red peaks show
fourfold molar excess of RhoA. Chemical shift changes were
deemed significant if the peak intensity was reduced by more than
80% (i.e. D145).
B. Homology model of EspM229–196 created with SWISS-MODEL
(Arnold et al., 2006). Data from the RhoA NMR titration (red) and
alanine mutations (blue) have been mapped onto the model. Those
residues with chemical shift changes in the NMR titrations and
which have also been mutated to alanines are coloured cyan.
C. Model of the EspM229–196–RhoA complex created by
superimposing the EspM229–196 model and the crystal structure of
RhoA (pdb:1xcg; Derewenda et al., 2004) onto the crystal structure
of the SopE–Cdc42 complex (pdb:1gzs; Buchwald et al., 2002). All
residues identified by the RhoA titration appear at the interface
except for those within the C-terminal helix. In this model the
intimate contacts with EspM2 are through the switch regions I and
II of RhoA.
658 A. Arbeloa et al.
© 2010 Blackwell Publishing Ltd, Cellular Microbiology, 12, 654–664
residues identify from NMR titration experiments lie within
the interface and are situated at both of the switch sites of
RhoA.
Site-directed mutagenesis of interface EspM2 residues
We introduced alanine substations in EspM2 residues
L118A, Q124A and I127A, which are located within the
EspM2 loop equivalent to the catalytic domain of SopE,
D73, which located within the WxxxE motif and N154,
which based on our RhoA-EspM2 model makes a hydro-
gen bond with the RhoA backbone. EspM2 W70A was
used as a control. The EspM229–196 derivatives were
expressed ectopically in Swiss 3T3 cells and formation of
stress fibres was assessed microscopically (Fig. 4). While
the W70A substitution completely abolished function,
Q124A substitution attenuated stress fibre formation
(seen in 35% of transfected cells compared with cells
transfected with wild-type EspM2) while L118A and I127A
reduced stress fibre formation by 56% and 65% respec-
tively (Fig. 4). N154A only had a minor effect on stress
fibres formation by EspM2 while no effect was detected
for D73A (Fig. 4). We tested representative EspM2
mutants delivered form E2348/69 by infection. Consistent
with the transfection data W70A and I127A did not trigger
stress fibres while D73A, N154A and Q124A triggered
stress fibres at levels comparable to the wild-type EspM2
(data not shown).
We next cloned espM2 W70A, L118A, Q124A and
I127A into pET28a for expression as 6His-tagged
EspM229–196. Despite repeated attempts we were unable
to purified EspM2 W70A and I127A, while the yield of
EspM2 L118A was very low. These results suggest that
these amino acids play an important structural role, which
is consistent with the 3D model (Fig. 3). The Q124A
mutant, purified at the same efficiency as the wild-type
EspM2, was used in SPR and GEF assays. No significant
difference in binding to RhoA was observed between wild-
type EspM2 and EspM2 Q124A (Fig. 4). Importantly,
EspM2 Q124A was attenuated in its ability to induce
loading of GTP into RhoA as 50 mM protein was needed to
achieve GTP loading equivalent to that induced by 1 mM
wild-type EspM2 (Fig. 4).
Discussion
When first described the WxxxE effectors were thought to
be molecular mimics of Rho GTPases (Alto et al., 2006).
Recent data have shown that IpgB1 activates the Rac1
GEF complex ELMO/Dock180 (Handa et al., 2007), and
Map, EspT and EspM activate Rho GTPases (Arbeloa
et al., 2008; Berger et al., 2009; Bulgin et al., 2009) by an
unknown mechanism. In this study we have investigated
the mechanism by which EspM2 activates RhoA.
Using surface plasmon resonance we found that
EspM229–196 forms a stable complex with nucleotide-free
RhoA. The dissociation of the EspM2–RhoA complex was
very slow and as a consequence we were unable to
measure the dissociation rate constant. We found that the
affinity of EspM229–196 to RhoA in presence of GDP or GTP
was lower than in absence of nucleotide, which is similar
to eukaryotic GEFs that also exhibit higher affinity and
form stable complexes with the nucleotide-free Rho
GTPases.
The initial step in nucleotide exchange is the formation
of a low-affinity complex between the GEF and the GDP-
bound Rho GTPase via recognition of the Switch I and II
regions (Klebe et al., 1995), which favours GDP and Mg2+
release. This is then rapidly converted into a high-affinity
GEF–GTPase binary complex (Lai et al., 1993); loading
with free GTP leads to dissociation of the GEF and for-
mation of a high-affinity Rho GTPase–GTP complex,
which binds subsequently downstream effectors (Milburn
et al., 1990). To test if EspM2 has a GEF activity we
incubated RhoA with mant-GTP and increasing concen-
trations of EspM229–196. We found that EspM229–196
induced loading of GTP into RhoA in a concentration-
dependent manner. This activity was specific for RhoA as
EspM229–196 induced weak nucleotide exchange in Cdc42,
while no nucleotide exchange was seen for Rac1 and the
distant GTPase H-Ras. Interestingly, the Salmonella
WxxxE effector SifA, which also binds RhoA, did not
exhibit a detectable GEF activity. It is not currently known
why binding to RhoA does not lead to nucleotide
exchange or if SifA can induce nucleotide exchange in
other small GTPases (e.g. Rab).
SopE from Salmonella was the first T3SS effector
described as a GEF (Hardt et al., 1998). SopE activates
Cdc42 and Rac1 leading to formation of membrane ruffles
and bacterial invasion. The crystal structure of the SopE–
Cdc42 complex illuminated the mechanism by which
SopE functions as GEF. SopE is composed of six
a-helices arranged in two three-helix bundles forming a
V-shape. The junction connecting the two arms consists
on small b sheet followed by a loop consisting of the
GAGA motif, which is proposed to be the catalytic loop of
SopE. Insertion of the GAGA motif between the switch
regions of Cdc42 induces a push and pull type movement
and release of GDP. Although SopE does not share
sequence or structural similarity with eukaryotic GEFs,
they induce similar conformational changes in the Rho
GTPases. Recently, the crystal structure of SifA in
complex with SKIP was solved (Ohlson et al., 2008).
While the N-terminal SifA domain binds SKIP, the
C-terminal domain, which shares no sequence similarity
with SopE and harbours the WxxxE motif, adopts a SopE-
like fold. NMR analysis of EspM229–196 combined with
homology modelling revealed that it likely contains six to
EspM2 is a RhoA GEF 659
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Fig. 4. Activity of EspM229–196 mutants.
A. Multiple sequence alignment of the putative catalytic loop and flanking regions of the WxxxE proteins: EspM2 of EHEC O157:H7 Sakai,
IpgB1 and IpgB2 of Shigella flexneri, EspT of Citrobacter rodentium, Map of EPEC E2348/69 and SifA and SifB of S. Typhimurium. The loop
region of SopE was added for comparison, with the catalytic region highlighted. Similar residues are highlighted in grey. A stretch of residues
in the putative catalytic loop of SifA that is different from the other WxxxE effectors is highlighted. EspM2 residues selected for mutagenesis
are indicated by a star.
B. Swiss 3T3 cells were transfected with pRK5 encoding myc-tagged EspM229–196, EspM229–196 W70A and EspM229–196 I127A. Actin was stained
with Oregon green phalloidin and the myc tag was detected with monoclonal antibody.
C. Quantification of stress fibres formation in cell transfected with different EspM229–196 mutants. Results are displayed as mean  SEM.
D. SPR comparison of RhoA binding to wild-type EspM2 and EspM2 Q124A. No significant difference in binding was detected over a range of
RhoA concentrations. Shown is the averaged response of three repeats.
E. EspM229–196 Q124A is impaired in loading mant-GTP into RhoA. mant-GTP (0.5 mM) was incubated with 2 mM RhoA in presence of 1 mM
EspM229–196 (blue circles) or 1 mM (green triangles), 5 mM (orange triangles) and 50 mM (red triangles) EspM229–196 Q124A.
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seven a-helices arranged in a V-shape structure similar to
SopE and SifA and a loop connecting the two arms
(Fig. S3). Interestingly, the sequence of this putative cata-
lytic loop is conserved between EspM229–196 and the other
WxxxE effectors, but not SifA (Fig. 4A), which might
provide an explanation as for why SifA cannot induce
nucleotide exchange in RhoA.
The tryptophan and glutamic acid of the WxxxE motif
have been shown to be essential as replacement of W or
E by alanine completely abolished the effectors’ function
(Alto et al., 2006; Arbeloa et al., 2008). However, we
recently found that conservative substitutions of the W
and E residues in EspM2 had little effect on stress fibre
formation, suggesting that they have a structural role. In
our model the W70 and E74 residues in EspM2 are posi-
tioned around the junction of the two three-helix bundles.
Consistently, the role proposed for these residues in SifA
was to maintain the conformation of the putative catalytic
loop through hydrophobic contacts with surrounding resi-
dues. Among these residues I258, the equivalent of I127
in EspM2, forms hydrophobic contacts with the tryp-
tophan and hydrophobic contacts and a hydrogen bond
with the glutamic acid (Ohlson et al., 2008). We observed
that alanine substitutions of W70 and I127 of EspM2
abolished almost completely its ability to induce forma-
tion of stress fibres. Despite repeated attempts we were
unable to purify His-tagged EspM2 W70 and I127 sug-
gesting that these residues play a role in maintaining the
global structure, which is consistent with the 3D model of
EspM2.
We use NMR to investigate how formation of a complex
with RhoA affects the conformation of EspM229–196. Titrat-
ing RhoA into 15N 13C-labelled EspM229–196 revealed spe-
cific protein interaction with most of the shifted peaks
being located either in the penultimate helix or in the
putative catalytic loop. Other than I127, substituting the
putative EspM catalytic loop residue L118 by alanine also
had a substantial effect on stress fibres formation;
however, the recombinant protein was highly unstable.
While this project was reaching conclusion, Huang et al.
(2009) published the crystal structure of the Map–Cdc42
complex and showed that Map induces guanine nucleotide
exchange in Cdc42 while IpgB2 and IpgB1 induce nucle-
otide exchange in RhoA and Rac1 respectively. In this
study it was shown that Map Q128, located within the
catalytic loop, makes a hydrogen bond with Cdc42 Phe37,
which fortifies the interaction between these two proteins.
Moreover Map Q128Y does not bind to, or induce nucle-
otide exchange in, Cdc42. Interestingly, while not affecting
the interaction of EspM2 with RhoA, EspM2 Q124A
(equivalent to Map Q128) was attenuated in stress fibre
formation by transfection and RhoA GEF activity; 50 mM
EspM2 Q124A was needed to achieve the same GEF
activity as 1 mM wild-type EspM2. Importantly, while muta-
tions affecting protein stability were inactive when deliv-
ered either by transfection or by infection, we did not detect
a significant effect on stress fibre formation when EspM2
Q124A (or D73A and N154A) were delivered by infection.
This suggests that upon translocation the local effector
concentration is high enough to induce nucleotide
exchange, compared with ectopic expression which leads
to global cytosolic distribution, low effector concentration
and hence an attenuated stress fibre formation.
The high-affinity complexes formed between GEFs and
their cognate Rho GTPases are quickly dissociated upon
addition of GTP or GDP. Unexpectedly we found that the
EspM229–196–RhoA and SifA–RhoA complexes did not
dissociate in the presence of exogenous nucleotides.
This result suggests that EspM2 could activate RhoA by
a unique mechanism, involving constitutive activation,
which allows recruitment of ROCK to the EspM2–RhoA
complex. Supporting this hypothesis is our finding that
upon infection of Swiss 3T3 cells with EPEC overexpress-
ing EspM2 the induced stress fibres were stable for at
least 5 h after the adherent bacteria were killed by gen-
tamicin (not shown). Moreover, Alto et al. (2006) have
shown that IpgB2 is co-immunoprecipitated with ROCK,
possibly via mutual interaction with RhoA.
In conclusion, our work shows that EspM2 is a RhoA
GEF. Importantly, a large screen of over 900 clinical EPEC
and EHEC isolates revealed that espM is found in c. 50%
of the strains (Arbeloa et al., 2009). It is now well docu-
mented that while 21 core effector genes are conserved in
all EPEC and EHEC strains, the distribution of the non-
conserved, accessory, effector genes varies from strain to
strains (Iguchi et al., 2009). This suggests that EPEC and
EHEC strains can employ different infection strategies.
Although the role of EspM2 during infection is not yet
known, a recent study by Simovitch et al. (2009) showed
that it is involved in delocalization of the thigh junctions
(TJ). Importantly, the TJ alterations induced by EspM2 did
not interfere with their functionality; on the contrary,
increased TER values were observed upon EspM2
expression. These results suggest that EspM2 might play
a role in maintaining TJ during infection. Moreover, EspM2
might modulate additional cellular pathways, as IpgB2
was recently implicated in activation of NF-kB in a RhoA-
ROCK-dependent manner (Fukazawa et al., 2008).
Further studies are needed in order to determine the role
played by EspM in vivo.
Experimental procedures
Bacterial strains and cell culture
Bacteria were grown from single colonies in Luria–Bertani (LB)
broth in a shaking incubator at 37°C or maintained on LB plates.
Culture medium was supplemented with ampicillin (100 mg ml-1)
or kanamycin (25 mg ml-1) as appropriate.
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Swiss 3T3 cells were maintained in DMEM with 4500 mg ml-1
glucose and supplemented with 10% fetal calf serum (Gibco) and
4 mM Glutamax (Gibco).
Plasmids and molecular techniques
Plasmids used in this study are listed in Table S1 in Support-
ing information; primers are listed in Table S2. espM2 and
espM229–196 were amplified by PCR using genomic EHEC
O157:H7 strain Sakai DNA as template and cloned into pET28
with non-cleavable N-terminal 6His tag or into the mammalian
expression vector pRK5 with an N-terminal myc tag. sifA was
amplified by PCR using genomic S. Typhimurium SL1344 DNA
as template and cloned into pET28 with an N-terminal 6His tag.
All constructs were verified by DNA sequencing.
The vector pMW172-His expressing RhoA or Rac1 fused to a
6His Tag was a gift from Michael Way.
Site-directed mutagenesis
Site-directed mutagenesis was carried out using a Quickchange
II kit (Stratagene) according to the manufacturer’s instructions.
Primers were designed using the Quickchange mutagenic primer
design program (Stratagene). Plasmids pRK5:espM229–196,
pET28:espM229–196 and pSA10:espM2 were used as template for
the mutagenic reactions. All constructs were verified by DNA
sequencing.
Preparation of recombinant proteins
Escherichia coli B834 containing pET28a (NdeI/BamHI inserted
espM229–196 or SifA) were grown at 310 K in LB broth containing
25 mg ml-1 kanamycin until an A600 of 0.6 was reached. Protein
overexpression was induced by the addition of 1.0 mM IPTG.
Cells were harvested after incubation at 293 K overnight (4500 g,
20 min, 277 K). Cell pellets were re-suspended in lysis buffer
(20 mM Tris pH 8, 500 mM NaCl, 1 mM DTT), complete EDTA-
free protease inhibitor cocktail (Roche) and homogenized. After
centrifugation (14 000 g, 30 min, 277 K), the soluble fraction was
applied to a 5 ml His trap FF Column (GE Healthcare) in a
gradient of 0–300 mM imidazole. EspM2 fractions were pooled
and purified using a Superdex 75 26/60 equilibrated in 20 mM
Tris pH 8, 500 mM NaCl, 10 mM DTT, high salt due to the insta-
bility of the protein. Protein was Liquid Nitrogen flash cooled and
frozen at 193 K on the same day, after experiencing protein
precipitation in samples kept at 277 K over 2–3 days.
Preparation of His-RhoA and His-Rac-1 was identical with the
following exceptions: expression was constitutive; cells were har-
vested after incubation at 310 K overnight. Lysis buffer was
20 mM Tris, 500 mM NaCl, 20 mM imidazole, 5 mM MgCl2. Size
exclusion buffer was 20 mM Tris, 200 mM NaCl, 3 mM MgCl2,
1 mM DTT.
Surface plasmon resonance
Experiments were carried out using a BIAcore™ 2000 System
(Biacore AB, Sweden) at 20°C. EspM229–196 was coupled to a
CM5 sensor chip leading to a rise of 2000 Response Units using
standard amine coupling protocols (BIAcore Amine Coupling Kit
BR-1000-50). Hepes-buffered saline containing 5 mM MgCl2 was
flowed throughout the experiment at 50 ml min-1. Samples of
RhoA/Rac-1 were injected (in the same buffer) for 180 s duration
over the EspM229–196 channel and over a RhoA control channel.
Dissociation was followed for 1000 s from the end of injection
after which regeneration of the surface was carried out with
25 mM NaOH. No loss of activity was seen after regeneration.
Experiments (repeated three times) were carried out with (i)
varying concentrations of RhoA (e = 18 825 M-1 cm-1) and Rac-1
(e = 23 295 M-1 cm-1) (concentration determined by Nanodrop
Spectrophotometer, 0.005–50 mM), and with (ii) fixed 4 mM RhoA
but varying concentrations of GDP/GTP (0.5–8 mM) added to the
buffer. RhoA control channel subtracted signals are presented
(BIAEvaluation software). The same conditions were used to
analyse the SifA–RhoA interaction.
Guanine nucleotide exchange analysis
In vitro GEF activity assay was carried out using RhoGEF
exchange assay biochem kit (Cytoskeleton Denver) according to
the manufacturer’s instructions. Briefly, exchange reaction assay
mixtures contained 20 mM Tris pH 7.5, 50 mM NaCl, 10 mM
MgCl2, 50 mg ml-1 bovine serum albumin (BSA), 0.75 mM
N-methylanthraniloyl(mant)-GTP, and 2 mM Rac1-His, Cdc42-
His, H-Ras-His or RhoA-His GTPase. Fluorescence spectro-
scopic analysis of mant-GTP was carried out using Fluostar
Optima spectrometer. The fluorescence measurements were
taken every 30 s with excitation and emission wavelengths of
360 nm and 440 nm respectively. After five readings (150 s),
purified EspM229–196 was added and the relative mant fluores-
cence was monitored every 30 s for a total time of 30 min. Experi-
ments were performed in triplicate.
NMR sample preparation and backbone assignment
of EspM229–196
Uniformly 15N 13C-labelled EspM229–196 was expressed in 15N 13C-
labelled rich media (Cambridge isotopes). After purification as
described above the sample was dialysed against NMR buffer
[50 mM NaPO4 pH 7.5, 150 mM NaCl, 5 mM DTT, 10% (v/v) D2O]
and concentrated to 0.9 mM. Backbone assignment for ~65% of
EspM229–196 was achieved using standard double- and triple-
resonance assignment experiments (Sattler et al., 1999) at
295 K.
NMR titration of RhoA against EspM229–196
15N 13C-labelled EspM229–196 was mixed with unlabelled His-RhoA
(dialysed in NMR buffer) ranging from 0x to 7x molar excess and
1H 15N TROSY-HSQC experiments were performed at each incre-
ment at 298 K. GTP (5 mM) was added to the sample of
EspM229–196 saturated with RhoA and a final 1H 15N TROSY-
HSQC was carried out.
Transfection
Swiss 3T3 cells were transfected with pRK5 encoding EspM2,
EspM229–196 and derivatives fused to a myc tag by lipofectamine
2000 (Invitrogen), according to the manufacturer’s recommenda-
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tions. The cells were incubated at 37°C in a humidified incubator
with 5% CO2 for 19 h, washed twice in PBS before having their
media replaced with DMEM as described previously (Arbeloa
et al., 2008).
Infection of Swiss 3T3
Forty-eight hours prior to infection cells were seeded onto glass
coverslips at a density of 5 ¥ 105 cells per well and maintained in
DMEM supplemented with 10% FCS at 37°C in 5% CO2. Three
hours before infection the cells were washed three times with
PBS, the media replaced with fresh DMEM without FCS and
500 ml of primed bacteria were added to each well and infections
were carried out for 90 min at 37°C in 5% CO2.
Immunofluorescence staining and microscopy
Swiss 3T3 cells on coverslips were washed three times in PBS
and fixed with 3% paraformaldehyde for 20 min before washing
three more times with PBS. For immunostaining, the cells were
permeabilized for 4 min in PBS 0.5% Triton X-100, washed three
times with PBS and quenched for 30 min with 50 mM NH4Cl. The
coverslips were then blocked for 1 h with 10% donkey serum
(Jackson laboratories) before incubation with primary and sec-
ondary antibodies. The primary antibody mouse anti-myc (Milli-
pore) was used at a dilution of 1:500. Coverslips were incubated
with the primary antibody for 1 h, washed three times in PBS and
incubated with the secondary antibody for 1 h. Donkey anti-
mouse IgG conjugated to a Cy3 fluorophore (Jackson laborato-
ries) was used at a 1:200. Actin was stained using Oregon Green
phalloidin (Invitrogen) at a 1:100 dilution. All dilutions were in 10%
donkey serum. Coverslips were mounted on slides using
ProLong Gold antifade reagent (Invitrogen) and visualized by
Zeiss Axioimager immunofluorescence microscope using the fol-
lowing excitation wavelengths: Cy3 – 550 nm, Cy5 – 650 nm and
Oregon Green – 488 nm. All images were analysed using the
Axiovision Rel 4.5 software.
Acknowledgements
We thank Michael Way for pMW172 derivatives expressing RhoA
or Rac1. We thank Clare Harding for cloning pET28:sifA and
Leah Ensell for technical assistance. This work was supported by
grants from the Wellcome Trust and the MRC.
References
Alto, N.M., Shao, F., Lazar, C.S., Brost, R.L., Chua, G.,
Mattoo, S., et al. (2006) Identification of a bacterial type III
effector family with G protein mimicry functions. Cell 124:
133–145.
Arbeloa, A., Bulgin, R.R., MacKenzie, G., Shaw, R.K., Pallen,
M.J., Crepin, V.F., et al. (2008) Subversion of actin dynam-
ics by EspM effectors of attaching and effacing bacterial
pathogens. Cell Microbiol 10: 1429–1441.
Arbeloa, A., Blanco, M., Moreira, F.C., Bulgin, R., Lopez, C.,
Dahbi, G., et al. (2009) Distribution of espM and espT
among enteropathogenic and enterohaemorrhagic
Escherichia coli. J Med Microbiol 58: 988–995.
Arnold, K., Bordoli, L., Kopp, J., and Schwede, T. (2006) The
SWISS-MODEL workspace: a web-based environment for
protein structure homology modelling. Bioinformatics 22:
195–201.
Berger, C.N., Crepin, V.F., Jepson, M.A., Arbeloa, A., and
Frankel, G. (2009) The mechanisms used by enteropatho-
genic Escherichia coli to control filopodia dynamics. Cell
Microbiol 11: 309–322.
Black, D.S., and Bliska, J.B. (2000) The RhoGAP activity of
the Yersinia pseudotuberculosis cytotoxin YopE is required
for antiphagocytic function and virulence. Mol Microbiol 37:
515–527.
Buchwald, G., Friebel, A., Galan, J.E., Hardt, W.D., Witting-
hofer, A., and Scheffzek, K. (2002) Structural basis for the
reversible activation of a Rho protein by the bacterial toxin
SopE. EMBO J 21: 3286–3295.
Bulgin, R.R., Arbeloa, A., Chung, J.C., and Frankel, G. (2009)
EspT triggers formation of lamellipodia and membrane
ruffles through activation of Rac-1 and Cdc42. Cell Micro-
biol 11: 217–229.
Deng, Q., and Barbieri, J.T. (2008) Modulation of host cell
endocytosis by the type III cytotoxin, Pseudomonas ExoS.
Traffic 9: 1948–1957.
Derewenda, U., Oleksy, A., Stevenson, A.S., Korczynska,
J., Dauter, Z., Somlyo, A.P., et al. (2004) The crystal
structure of RhoA in complex with the DH/PH fragment
of PDZRhoGEF, an activator of the Ca(2+) sensitiza-
tion pathway in smooth muscle. Structure 12: 1955–1965.
Finlay, B.B. (2005) Bacterial virulence strategies that
utilize Rho GTPases. Curr Top Microbiol Immunol 291:
1–10.
Fu, Y., and Galan, J.E. (1999) A Salmonella protein antago-
nizes Rac-1 and Cdc42 to mediate host-cell recovery after
bacterial invasion. Nature 401: 293–297.
Fukazawa, A., Alonso, C., Kurachi, K., Gupta, S., Lesser,
C.F., McCormick, B.A., and Reinecker, H.C. (2008)
GEF-H1 mediated control of NOD1 dependent
NF-kappaB activation by Shigella effectors. PLoS Pathog
4: e1000228.
Goehring, U.M., Schmidt, G., Pederson, K.J., Aktories, K.,
and Barbieri, J.T. (1999) The N-terminal domain of
Pseudomonas aeruginosa exoenzyme S is a GTPase-
activating protein for Rho GTPases. J Biol Chem 274:
36369–36372.
Hall, A., Paterson, H.F., Adamson, P., and Ridley, A.J. (1993)
Cellular responses regulated by rho-related small GTP-
binding proteins. Philos Trans R Soc Lond B Biol Sci 340:
267–271.
Handa, Y., Suzuki, M., Ohya, K., Iwai, H., Ishijima, N.,
Koleske, A.J., et al. (2007) Shigella IpgB1 promotes bac-
terial entry through the ELMO–Dock180 machinery. Nat
Cell Biol 9: 121–128.
Hardt, W.D., Chen, L.M., Schuebel, K.E., Bustelo, X.R., and
Galan, J.E. (1998) S. typhimurium encodes an activator of
Rho GTPases that induces membrane ruffling and nuclear
responses in host cells. Cell 93: 815–826.
Huang, Z., Sutton, S.E., Wallenfang, A.J., Orchard, R.C., Wu,
X., Feng, Y., et al. (2009) Structural insights into host
GTPase isoform selection by a family of bacterial GEF
mimics. Nat Struct Mol Biol 16: 853–860.
Iguchi, A., Thomson, N.R., Ogura, Y., Saunders, D., Ooka, T.,
EspM2 is a RhoA GEF 663
© 2010 Blackwell Publishing Ltd, Cellular Microbiology, 12, 654–664
Henderson, I.R., et al. (2009) Complete genome sequence
and comparative genome analysis of enteropathogenic
Escherichia coli O127:H6 strain E2348/69. J Bacteriol 191:
347–354.
Jaffe, A.B., and Hall, A. (2005) Rho GTPases: biochemistry
and biology. Annu Rev Cell Dev Biol 21: 247–269.
Jones, D.T. (1999) Protein secondary structure prediction
based on position-specific scoring matrices. J Mol Biol 292:
195–202.
Klebe, C., Prinz, H., Wittinghofer, A., and Goody, R.S. (1995)
The kinetic mechanism of Ran-nucleotide exchange cata-
lyzed by RCC1. Biochemistry 34: 12543–12552.
Lai, C.C., Boguski, M., Broek, D., and Powers, S. (1993)
Influence of guanine nucleotides on complex formation
between Ras and CDC25 proteins. Mol Cell Biol 13: 1345–
1352.
Matsuzawa, T., Kuwae, A., Yoshida, S., Sasakawa, C., and
Abe, A. (2004) Enteropathogenic Escherichia coli activates
the RhoA signaling pathway via the stimulation of GEF-H1.
EMBO J 23: 3570–3582.
Milburn, M.V., Tong, L., Vos, A.M., Brunger, A., Yamaizumi,
Z., Nishimura, S., and Kim, S.H. (1990) Molecular switch
for signal transduction: structural differences between
active and inactive forms of protooncogenic ras proteins.
Science 247: 939–945.
Mota, L.J., and Cornelis, G.R. (2005) The bacterial injection
kit: type III secretion systems. Ann Med 37: 234–249.
Ohlson, M.B., Huang, Z., Alto, N.M., Blanc, M.P., Dixon, J.E.,
Chai, J., and Miller, S.I. (2008) Structure and function of
Salmonella SifA indicate that its interactions with SKIP,
SseJ, and RhoA family GTPases induce endosomal tubu-
lation. Cell Host Microbe 4: 434–446.
Rossman, K.L., Worthylake, D.K., Snyder, J.T., Siderovski,
D.P., Campbell, S.L., and Sondek, J. (2002) A crystallo-
graphic view of interactions between Dbs and Cdc42: PH
domain-assisted guanine nucleotide exchange. EMBO J
21: 1315–1326.
Rudolph, M.G., Weise, C., Mirold, S., Hillenbrand, B., Bader,
B., Wittinghofer, A., and Hardt, W.D. (1999) Biochemical
analysis of SopE from Salmonella typhimurium, a highly
efficient guanosine nucleotide exchange factor for RhoGT-
Pases. J Biol Chem 274: 30501–30509.
Sattler, M., Schleucher, J., and Griesinger, C. (1999) Hetero-
nuclear multidimensional NMR experiments for the struc-
ture determination of proteins in solution employing pulsed
field gradients. Prog NMR Spectrosc 34: 93–158.
Simovitch, M., Sason, H., Cohen, S., Zahavi, E.E., Melamed-
Book, N., Weiss, A., et al. (2009) EspM inhibits pedestal
formation by EHEC and EPEC and disrupts the architec-
ture of a polarized epithelial monolayer. Cell Microbiol
Doi: 10.1111/j.1462-5822.2009.01410.x.
Stevens, M.P., Friebel, A., Taylor, L.A., Wood, M.W., Brown,
P.J., Hardt, W.D., and Galyov, E.E. (2003) A Burkholderia
pseudomallei type III secreted protein, BopE, facilitates
bacterial invasion of epithelial cells and exhibits guanine
nucleotide exchange factor activity. J Bacteriol 185: 4992–
4996.
Tobe, T., Beatson, S.A., Taniguchi, H., Abe, H., Bailey, C.M.,
Fivian, A., et al. (2006) An extensive repertoire of type III
secretion effectors in Escherichia coli O157 and the role of
lambdoid phages in their dissemination. Proc Natl Acad Sci
USA 103: 14941–14946.
Von Pawel-Rammingen, U., Telepnev, M.V., Schmidt, G.,
Aktories, K., Wolf-Watz, H., and Rosqvist, R. (2000) GAP
activity of the Yersinia YopE cytotoxin specifically targets
the Rho pathway: a mechanism for disruption of actin
microfilament structure. Mol Microbiol 36: 737–748.
Wishart, D.S., Sykes, B.D., and Richards, F.M. (1993)
Improved synthetic methods for the selective deuteration of
aromatic amino acids: applications of selective protonation
towards the identification of protein folding intermediates
through nuclear magnetic resonance. Biochim Biophys
Acta 1164: 36–46.
Supporting information
Additional Supporting Information may be found in the online
version of this article:
Appendix S1. Supplementary results.
Fig. S1. 1H 15N HSQC spectra of EspM2 constructs at 295 K.
A. Full-length EspM2 where the overlapping peaks within the
centre of the spectra are due to resonances from highly flexible
regions of the protein.
B. The much increased resolution of the spectra of EspM229–196
shows that this truncated form is a compact structure with an
appropriate number of amide peaks.
Fig. S2. Activity of EspM229–196.
A. Serum-starved Swiss 3T3 cells were mock transfected or
transfected with the mammalian expression vector pRK5 encod-
ing myc-tagged EspM2 and EspM229–196 for 19 h. Actin was
stained with Oregon green phalloidin and the myc tag was
detected with monoclonal antibody. Transfection of EspM2 and
EspM229–196 induces the formation of parallel stress fibres to the
same extent.
B. Quantification of stress fibres on Swiss 3T3 after 19 h trans-
fection with EspM2 and EspM229–196. Fifty cells were counted in
duplicate in three independent experiments. Results are dis-
played as mean  SEM.
Fig. S3. Secondary structure of EspM229–196. From the NMR
chemical shift index (CSI) (Wishart et al., 1993), predictions with
PSIPRED (Jones, 1999) and a model based on the crystal struc-
ture of the C-terminal domain of SifA (pdb:3cxb; Ohlson et al.,
2008) EspM229–196 most likely contains between six and seven
helices and two short N-terminal helices. Helices are shown as
red rectangles, sheets as blue arrows, coils and loops are grey
lines while regions in the CSI which have not been assigned are
left blank.
Table S1. List of plasmids.
Table S2. List of primers.
Please note: Wiley-Blackwell are not responsible for the content
or functionality of any supporting materials supplied by the
authors. Any queries (other than missing material) should be
directed to the corresponding author for the article.
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